calander 7–9 APRIL 2026
location ADNEC CENTRE ABU DHABI, UAE

HealthBeats Podcast

The official podcast of Abu Dhabi Global Health Week, HealthBeats is your ultimate source for transformative insights into the future of global healthcare. Through engaging conversations with industry pioneers, policymakers, and changemakers, HealthBeats highlights how innovation, collaboration, and forward-thinking policies are shaping the next generation of healthcare.

img 08 August 2025

The Rise of Digital Mental Health in Abu Dhabi. #Ep.33

In this powerful conversation, Dr Zain Ali Al Yafei, CEO of Sakina, an asset of PureHealth, shares how they are transforming mental health care in Abu Dhabi, one citizen at a time, through the innovative Pura app.

img 01 August 2025

From Sickcare to Healthcare: Rewriting the Future of Global Wellness. #Ep.32

In this visionary episode, Reenita Das, Partner & Senior Vice President at Frost & Sullivan, unpacks the urgent shift from reactive "sickcare" systems to proactive, outcome-driven healthcare. She introduces the concept of wellness insurance a model that focuses on keeping people well through preventive screenings and early intervention, rather than just treating illness after it strikes.
MEET THE SPEAKER

Meet our expert guest speaker

Ms. Reenita Das
Ms. Reenita Das

Partner, Senior Vice President

Frost and Sullivan

img 25 July 2025

The medicine journey - how new drugs are developed and brought to market #Ep.31

In this episode of the HealthBeats podcast, Martin Price, Vice President of Health Economics, Market Access and Reimbursement at Johnson & Johnson Innovative Medicine, EMEA, shares insights into the complex journey of bringing new medications to market. From early discovery, testing and regulation for new medications, this episode explores how innovation meets real-world access in today's healthcare landscape.

img 18 July 2025

Unlocking the Power of the Genome: Precision Medicine & the Future of Biopharma. #Ep.30

In this episode, Steve Gardner sits down with Paul Jones, CEO of Biopharma Solutions at M42, to explore the transformative potential of genomic science across the biopharma value chain and more. From large-scale DNA sequencing to the real-world applications of genomics in personalising medicine, Paul shares how this powerful technology is reshaping drug development, disease prediction, and clinical trials.